Sun Pharma gets USFDA import ban on Gujarat plant

The United States Food and Drug Administration (USFDA) has imposed an import alert, effectively a ban, on generic drugmaker Sun Pharmaceutical Industries Ltd's plant in Gujarat.

An "import alert" results in the detention without physical examination of drugs from firms that have not met so-called good manufacturing practices, according to the FDA website.

A spokesman for Sun, India's biggest drugmaker by market value, was not available for comment.

The plant in Karkhadi in Gujarat makes both drug ingredients and formulations, according to Sun's 2013 annual report.

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

EDITORIAL OF THE DAY

  • Tax offenders stashing black money abroad must be booked

    There can be little doubt that for the government to get at those salting away unaccounted and untaxed money in foreign banks is a long overdue exerci

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

Chander Mohan Sethi

CMD, Reckitt Benckiser India

COLUMNIST

Arun Nigavekar

Riding the product startup wave

That the Indian youth is undergoing a massive change in ...

Zehra Naqvi

Rememberance and forgetting are crucial

Memories are so vital to our lives that they can ...

Dharmendra Khandal

Sandalwood may get extinct if not protected

When we talk of sandalwood, the most common usage that ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture